Literature DB >> 22930311

Validity of reported Medicare Part D enrollment in the Medical Expenditure Panel Survey.

Steven C Hill1, Samuel H Zuvekas, Marc W Zodet.   

Abstract

The authors validate reported Part D coverage in the Medical Expenditure Panel Survey (MEPS) and assess the impact of misreporting on descriptive and behavioral analyses. MEPS participants with Medicare coverage during 2006 to 2007 were matched to Medicare administrative data. A summary measure of Part D coverage based on several questions has substantial validity (κ = .70) and an agreement rate of 85.1%. Some beneficiaries confused Part D and private drug coverage, leading to both under- and overreported Part D coverage. Accuracy varies little by sociodemographic group. Standard regression models of the determinants of Part D enrollment were estimated with both MEPS-based and administrative data-based measures of Part D enrollment. In this analysis, the signs of the marginal effects were the same, the magnitudes were similar, and mostly the same variables had statistically significant effects in both regressions. Thus, behavioral analyses are largely unaffected by misreporting.

Entities:  

Mesh:

Year:  2012        PMID: 22930311     DOI: 10.1177/1077558712457595

Source DB:  PubMed          Journal:  Med Care Res Rev        ISSN: 1077-5587            Impact factor:   3.929


  3 in total

1.  Impact of Medicare Age Eligibility on Health Spending among U.S. and Foreign-Born Adults.

Authors:  Wassim Tarraf; Gail A Jensen; Hector M González
Journal:  Health Serv Res       Date:  2015-10-20       Impact factor: 3.402

2.  Assessing incentives for service-level selection in private health insurance exchanges.

Authors:  Thomas G McGuire; Joseph P Newhouse; Sharon-Lise Normand; Julie Shi; Samuel Zuvekas
Journal:  J Health Econ       Date:  2014-02-17       Impact factor: 3.883

3.  Assessing Medicare Part D claim completeness using medication self-reports: the role of veteran status and Generic Drug Discount Programs.

Authors:  Lei Zhou; Sally C Stearns; Emily M Thudium; Khalid A Alburikan; Jo E Rodgers
Journal:  Med Care       Date:  2015-05       Impact factor: 2.983

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.